In 2019, the SARS-CoV-2 virus caused one of the biggest virus pandemics called Coronavirus disease-19 (COVID-19). This virus has been responsible for the death of millions of people around the world. The biological function of SARS-CoV-2 and its pathophysiology mechanisms, as well as the host immunity against this virus, has attracted the attention of the scientific community all over the world. The current study reviewed innate and acquired immune responses following COVID-19 infection. These immune responses are probably involved in the severity of the disease and death. Also, the cause and consequence of potential clinical strategies to treat or prevent SARS-CoV-2 infection have been proposed.
Purpose Glioblastoma multiforme (GBM) is a common brain tumor with aggressive phenotypes and resistance to treatments. Erlotinib and Imatinib, combined, hold promise as innovative therapies to overcome GBM's heterogeneous malignancy. This study conducted experiments in two-dimensional (2D) and three-dimensional (3D) cell cultures, comparing them to the in vivo microenvironment. Methods The study measured the effects of Imatinib and Erlotinib on the survival of 2D and 3D cell cultures and apoptosis after 24 and 48 hours (h) post-treatment using MTT assay and flow cytometry. The study also investigated gene expression of Bcl-2 and VEGF using qRT-PCR. The scratch test was used to explore drug treatments' effects on cellular migration. Results Based on our results, combination therapy reduced tumor cell migration by reducing Bcl-2 and VEGF gene expression through Erlotinib, Imatinib, or combination therapy. However, combination therapy showed a more significant reduction in B-cl2 gene expression than single therapy, as opposed to VEGF expression. The apoptotic effect of combination therapy was confirmed, with an increase in death percentage in the 48h-3D treated group (*P < 0.05 for monotherapy and ***P < 0.001 for combination). Conclusion 3D culture offers a more physiological environment for studying oncolytic drug effects. In a 3D in vitro study, combination GBM therapy caused significant apoptosis, requiring further preclinical model studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.